Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Biopharmx Corporatio (BPMX)

0.45 -0.01 (-1.96%)

6/23/2017  4:02pm

Open:

0.47

Pre. Close:

0.46

High:

0.47

Low:

0.43

Volume:

537,071

Market Cap:

33.36M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.52 - 0.51

0.51 - 0.49

Low:

0.4 - 0.41

0.41 - 0.43

Close:

0.44 - 0.45

0.45 - 0.46

Technical analysis  (as of: 2017-06-23 4:32:47 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 0.72     One year: 0.88

Support:

Support1: 0.40    Support2: 0.33

Resistance:

Resistance1: 0.62    Resistance2: 0.75

Pivot:

0.50

Moving Averages:

MA(5): 0.45     MA(20): 0.52

MA(100): 0.54     MA(250): 0.53

MACD:

MACD(12,26): -0.04     Signal(12,26,9): -0.03

%K %D:

%K(14,3): 17.44     %D(3): 14.46

RSI:

RSI(14): 40.49

52-Week:

High: 1.22  Low: 0.19  Change(%): -34.8

Average Vol(K):

3-Month: 3039  10-Days 354

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
BPMX has closed above bottom band by 28.1%. Bollinger Bands are 7.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 27 Mar 2017 18:45:00 GMT
BioPharmX Has A Major Upcoming Catalyst

Wed, 14 Jun 2017 13:06:58 GMT
BioPharmX Invited to Present at World Preclinical Congress

Thu, 22 Jun 2017 20:26:15 GMT
Shares Seesawing on Volume: Biopharmx Corp (BPMX)

Thu, 01 Jun 2017 12:11:15 GMT
BRIEF-Biopharmx advances BPX-01 2 pct upon achieving statistical significance ...

Wed, 07 Jun 2017 10:17:09 GMT
BioPharmX to Report First Quarter Financial Results

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

74.13

Shares Float (M)

44.79

% Held by Insiders

1.06

% Held by Institutions

2.90

Shares Short (K)

3690

Shares Short Prior Month (K)

3440

Stock Financials

EPS

-0.518

EPS Est. Current Year

-0.330

EPS Est. Next Year

-0.340

EPS Est. Next Quarter

-0.070

Forward EPS

-0.337

Book Value (p.s.)

0.020

PEG Ratio

Profit Margin

Operating Margin

-18337.00

Return on Assets (ttm)

-191.8

Return on Equity (ttm)

-732.6

Qtrly Rev. Growth

-57.1

Gross Profit (p.s.)

-0.006

Sales Per Share

EBITDA (p.s.)

-0.246

Qtrly Earnings Growth

Operating Cash Flow (M)

-15.75

Levered Free Cash Flow (M)

-9.01

FoxReading.com

Valuation

P/E

-0.87

P/E Growth Ratio

-0.02

P/BV

22.50

P/S

P/CF

-2.12

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.